Fair Value of Financial Instruments (Tables)

9 Months Ended

Sep. 28, 2025

Fair Value Disclosures [Abstract]

Schedule of Fair Value Hierarchy

The Company had the following assets and liabilities measured at fair value in its Consolidated Balance Sheets:

	Fair Value Measurements Using:
	Fair Value		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
September 28, 2025
Assets:
Available-for-sale securities	$	55.9	$	55.9	$	—	$	—
Derivatives	1.0		—		1.0		—
Total assets	$	56.9	$	55.9	$	1.0	$	—
Liabilities:
Derivatives	$	8.6	$	—	$	8.6	$	—
Total liabilities	$	8.6	$	—	$	8.6	$	—

	Fair Value Measurements Using:
	Fair Value		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
September 29, 2024
Assets:
Short-term investments	$	489.3	$	489.3	$	—	$	—
Available-for-sale securities	0.6		0.6		—		—
Derivatives	3.4		—		3.4		—
Total assets	$	493.3	$	489.9	$	3.4	$	—
Liabilities:
Derivatives	$	5.9	$	—	$	5.9	$	—
Option agreement	1.7		—		—		1.7
Total liabilities	$	7.6	$	—	$	5.9	$	1.7
December 29, 2024
Assets:
Available-for-sale securities	$	0.6	$	0.6	$	—	$	—
Derivatives	9.7		—		9.7		—
Total assets	$	10.3	$	0.6	$	9.7	$	—
Liabilities:
Derivatives	$	1.7	$	—	$	1.7	$	—
Total Liabilities	$	1.7	$	—	$	1.7	$	—